Anterior pituitary hormones actions

Table 8-2. Actions of Hypothalamic and Anterior Pituitary Hormones...

Three of the seven anterior pituitary hormones do not act on endocrine glands, but influence tissue metabolism directly. There is no hormone feedback mechanism for the control of these three hormones, and control is exerted by the action of release-inhibiting hormones. 

McCann SM, Vijayan E, Negro-Vilar A, Mizunuma Ft, Mangat Ft. Gamma aminobu-tyric acid (GABA), a modulator of anterior pituitary hormone secretion by hypothalamic and pituitary action. Psychoneuroendocrinology F984 9 97-F06. 

Hormones have a profound effect on carbohydrate metabolism. Great interest has been aroused by reports of hormonal control of hexokinase activity by specific proteins in animal tissues.99- 100 Hexokinase action is the rate-limiting step in the uptake of D-glucose by muscle. Hexokinase is inhibited in diabetic muscle, but the inhibition can be partially reversed by insulin. A protein fraction from the anterior pituitary gland will inhibit the hexokinase of extracts of brain and muscle, and the effect of this... 

Yin P, Kawashima K, Arita J (2002) Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependentlactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats. Neuroendocrinology... 

GC, in turn, exert a very sensitive negative feedback on the HPA system at the level of the paraventricular nucleus of the hypothalamus (PVN) and the anterior pituitary, and also at the level of the hippocampus, which projects to the bed nucleus of the stria terminalis, the latter which sends off projections to the PVN. In concert with other components of the stress hormone system, the action of corticosterone displays two modes of operation (for review see De Kloet et al. 1998). In the first proactive mode, GC maintain basal activity of the HPA system and control the sensitivity or threshold of the system s response to stress. GC promote coordination of circadian events, such as the... 

Mechanism of Action A hormone and antineoplastic agent that suppresses the release of luteinizing hormone from the anterior pituitary gland by inhibiting pituitary function. Therapeutic Effect Shrinks tumors. Also increases appetite by an unknown mechanism. 

The correlation of the hypothalamus and its hormones with the hormones of the anterior pituitary gland is summarized in figure 5.2. There is no direct vascular connection between the hypothalamus and the posterior lobe of the pituitary that would correspond to the portal vein system for the anterior lobe of the gland. Not all hypothalamo-pituitary hormones will be discussed in the subsequent sections. Only those that are well-defined chemical entities or have a direct connection with drug action are considered. 

The hypothalamic control of the posterior pituitary is quite different than that of the anterior and intermediate lobes. Specific neurons have their cell bodies in certain hypothalamic nuclei. Cell bodies in the paraventricular nuclei manufacture oxytocin, whereas the supraoptic nuclei contain cell bodies that synthesize ADH. The axons from these cells extend downward through the infundibulum to terminate in the posterior pituitary. Hormones synthesized in the hypothalamic cell bodies are transported down the axon to be stored in neurosecretory granules in their respective nerve terminals (located in the posterior pituitary). When an appropriate stimulus is present, these neurons fire an action potential, which causes the hormones to release from their pituitary nerve terminals. The hormones are ultimately picked up by the systemic circulation and transported to their target tissues. 

Dopamine can thus be added to the list of hormones and neurotransmitters which can stimulate or inhibit cyclic AMP formation, depending upon their tissue of action. Thus, while dopamine stimulates cyclic AMP formation in parathyroid cells, superior cervical ganglia, retina and striatal tissue (27, 58-61), it inhibits the accumulation of the cyclic nucleotide in cells of the intermediate and anterior lobes of the pituitary gland. Opposite effects on the cyclic AMP system are also found with LHRH which stimulates and inhibits cyclic AMP levels in the anterior pituitary gland (62) and ovary (63), respectively. Similarly, alpha-adrenergic agents show opposite effects on cyclic AMP formation in brain (64) and platelets (65). PGE, stimulates cyclic AMP formation in the anterior pituitary gland (62) while it inhibits the same parameter in fat cells (66). 

The thyroid-pituitary-hypothalamus axis controls thyroid hormone homeostasis. Thyrotropin-releasing hormone (TRH), released from the hypothalamus, stimulates the synthesis and release of thyroid-stimulating hormone (thyrotropin, TSH) from the anterior pituitary. TSH increases the release of thyroid hormones by several mechanisms, including stimulation of the I pump. While lower than normal levels of T3 and T4 cause an exaggerated response of the pituitary to TRH, released thyroid hormones, in feedback control, blunt the stimulating action of TRH on the pituitary. For further discussion of TSH and TRH biochemistry, see, for example, the review by Kannan48. 

---